Antonios Keramopoulos

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Konstantopoulou Irene; Rampias Theodore; Ladopoulou Angela; Koutsodontis George; Armaou Sophia; Anagnostopoulos Theodore; Nikolopoulos George; Kamakari Smaragda; Nounesis George; Stylianakis Antonis; Karanikiotis Charisios; Razis Evangelia; Gogas Helen; Keramopoulos Antonios; Gaki Vassiliki; Markopoulos Christos; Skarlos Dimosthenis; Pandis Nikos; Bei Thalia; Arzimanoglou Iordanis; Fountzilas George; Yannoukakos Drakoulis
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.
Mylona E; Nomikos A; Alexandrou P; Giannopoulou I; Keramopoulos A; Nakopoulou L
Lymphatic and blood vessel morphometry in invasive breast carcinomas: relation with proliferation and VEGF-C and -D proteins expression.
Nakopoulou Lydia; Panayotopoulou Effie G; Giannopoulou Ioanna; Tsirmpa Ioanna; Katsarou Sophia; Mylona Eleni; Alexandrou Paraskevi; Keramopoulos Antonios
Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Antonios Keramopoulos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Konstantopoulou Irene; Rampias Theodore; Ladopoulou Angela; Koutsodontis George; Armaou Sophia; Anagnostopoulos Theodore; Nikolopoulos George; Kamakari Smaragda; Nounesis George; Stylianakis Antonis; Karanikiotis Charisios; Razis Evangelia; Gogas Helen; Keramopoulos Antonios; Gaki Vassiliki; Markopoulos Christos; Skarlos Dimosthenis; Pandis Nikos; Bei Thalia; Arzimanoglou Iordanis; Fountzilas George; Yannoukakos Drakoulis
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.
Breast cancer research and treatment 2008;107(3):431-41.
2007: Mylona E; Nomikos A; Alexandrou P; Giannopoulou I; Keramopoulos A; Nakopoulou L
Lymphatic and blood vessel morphometry in invasive breast carcinomas: relation with proliferation and VEGF-C and -D proteins expression.
Histology and histopathology 2007;22(8):825-35.
2007: Nakopoulou Lydia; Panayotopoulou Effie G; Giannopoulou Ioanna; Tsirmpa Ioanna; Katsarou Sophia; Mylona Eleni; Alexandrou Paraskevi; Keramopoulos Antonios
Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis.
Journal of clinical pathology 2007;60(7):808-15.
2007: Mylona E; Alexandrou P; Mpakali A; Giannopoulou I; Liapis G; Markaki S; Keramopoulos A; Nakopoulou L
Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2007;33(3):294-300.
2007: Mylona Eleni; Alexandrou Paraskevi; Giannopoulou Ioanna; Liapis George; Sofia Markaki; Keramopoulos Antonios; Nakopoulou Lydia
The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma.
Gynecologic oncology 2007;104(3):557-63.
2007: Giannopoulou I; Mylona E; Kapranou A; Mavrommatis J; Markaki S; Zoumbouli Ch; Keramopoulos A; Nakopoulou L
The prognostic value of the topographic distribution of uPAR expression in invasive breast carcinomas.
Cancer letters 2007;246(1-2):262-7.
2007: Liapis George; Mylona Eleni; Alexandrou Paraskevi; Giannopoulou Ioanna; Nikolaou Irini; Markaki Sofia; Keramopoulos Antonios; Nakopoulou Lydia
Effect of the different phosphorylated Smad2 protein localizations on the invasive breast carcinoma phenotype.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2007;115(2):104-14.
2007: Mylona E; Nomikos A; Magkou C; Kamberou M; Papassideri I; Keramopoulos A; Nakopoulou L
The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma.
Histopathology 2007;50(3):338-47.
2006: Georgopoulos Neoklis A; Adonakis George L; Fotopoulos Andreas; Koika Vasiliki; Spinos Nikitas; Saltamavros Alexandros; Keramopoulos Antonios; Koukouras Dimitrios; Decavalas George; Kourounis George S
Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2006;22(4):185-9.
2006: Nakopoulou Lydia; Mylona Eleni; Papadaki Ioanna; Kavantzas N; Giannopoulou I; Markaki S; Keramopoulos A
Study of phospho-beta-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(4):556-63.
2006: Mylona Eleni; Magkou Christina; Giannopoulou Ioanna; Agrogiannis George; Markaki Sofia; Keramopoulos Antonios; Nakopoulou Lydia
Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome.
Breast cancer research : BCR 2006;8(5):R57.
2006: Mylona Eleni E; Alexandrou Paraskevi Th; Giannopoulou Ioanna A; Rafailidis Petros I; Markaki Sofia; Keramopoulos Antonios; Nakopoulou Lydia L
Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype.
Cancer detection and prevention 2006;30(2):111-7.
2005: Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
Climacteric : the journal of the International Menopause Society 2005;8(4):342-51.
2005: Nakopoulou L; Mylona E; Rafailidis P; Alexandrou P; Giannopoulou I; Keramopoulos A
Effect of different ERK2 protein localizations on prognosis of patients with invasive breast carcinoma.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2005;113(10):693-701.
2005: Mylona E; Kapranou A; Mavrommatis J; Markaki S; Keramopoulos A; Nakopoulou L
The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2005;113(4):246-55.
2005: Papadaki I; Mylona E; Giannopoulou I; Markaki S; Keramopoulos A; Nakopoulou L
PPARgamma expression in breast cancer: clinical value and correlation with ERbeta.
Histopathology 2005;46(1):37-42.
2005: Nakopoulou L; Mylona E; Papadaki I; Kapranou A; Giannopoulou I; Markaki S; Keramopoulos A
Overexpression of cyclooxygenase-2 is associated with a favorable prognostic phenotype in breast carcinoma.
Pathobiology : journal of immunopathology, molecular and cellular biology 2005;72(5):241-9.
2004: Dimitrakakis C; Gosselink L; Gaki V; Bredakis N; Keramopoulos A
Phytoestrogen supplementation: a case report of male breast cancer.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2004;13(6):481-4.
2004: Belogianni Ioulia; Apessos Angela; Mihalatos Markos; Razi Evangelia; Labropoulos Stefanos; Petounis Andreas; Gaki Vasiliki; Keramopoulos Antonios; Pandis Nikos; Kyriacou Kyriacos; Hadjisavvas Andreas; Kosmidis Paris; Yannoukakos Drakoulis; Nasioulas Georgios
Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer.
BMC cancer 2004;4():61.
2004: Yannakoulia Mary; Keramopoulos Antonios; Matalas Antonia-Leda
Bone mineral density in young active females: the case of dancers.
International journal of sport nutrition and exercise metabolism 2004;14(3):285-97.
2004: Nakopoulou L; Lazaris A C; Panayotopoulou E G; Giannopoulou I; Givalos N; Markaki S; Keramopoulos A
The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.
Journal of clinical pathology 2004;57(5):523-8.
2004: Dimitrakakis C; Keramopoulos A
Survival in primary inoperable breast cancer patients.
European journal of gynaecological oncology 2004;25(3):367-72.
2003: Nakopoulou L; Giannopoulou I; Lazaris A Ch; Alexandrou P; Tsirmpa I; Markaki S; Panayotopoulou E; Keramopoulos A
The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(11):1027-36.
2002: Nakopoulou Lydia; Panayotopoulou Effie G; Giannopoulou Ioanna; Alexandrou Paraskevi; Katsarou Sophia; Athanassiadou Pauline; Keramopoulos Antonios
Stromelysin-3 protein expression in invasive breast cancer: relation to proliferation, cell survival and patients' outcome.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(11):1154-61.
2002: Nakopoulou L; Gakiopoulou-Givalou H; Karayiannakis A J; Giannopoulou I; Keramopoulos A; Davaris P; Pignatelli M
Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival.
Histopathology 2002;40(6):536-46.
2002: Nakopoulou Lydia; Giannopoulou Ioanna; Trafalis Dimitrios; Gakiopoulou Hariklia; Keramopoulos Antonios; Davaris Panayiotis
Evaluation of numeric alterations of chromosomes 1 and 17 by in situ hybridization in invasive breast carcinoma with clinicopathologic parameters.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2002;10(1):20-8.
2002: Nakopoulou Lydia; Katsarou Sophia; Giannopoulou Ioanna; Alexandrou Paraskevi; Tsirmpa Ioanna; Panayotopoulou Effie; Mavrommatis Johnny; Keramopoulos Antonios
Correlation of tissue inhibitor of metalloproteinase-2 with proliferative activity and patients' survival in breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(1):26-34.
2001: Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Stipsanelli A; Louvrou A; Lazaris D; Sotiropoulou M; Pampouras G; Keramopoulos A; Michalas S; Zerva C
99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
European journal of nuclear medicine 2001;28(7):923-8.
2001: Karayiannakis A J; Nakopoulou L; Gakiopoulou H; Keramopoulos A; Davaris P S; Pignatelli M
Expression patterns of beta-catenin in in situ and invasive breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2001;27(1):31-6.
2000: Papantoniou V; Sotiropoulou M; Stipsaneli E; Louvrou A; Feda H; Christodoulidou J; Pampouras G; Zerva C; Keramopoulos A; Michalas S
Scintimammographic findings of in situ ductal breast carcinoma in a double-phase study with Tc-99m(V) DMSA and Tc-99m MIBI value of Tc-99m(V) DMSA.
Clinical nuclear medicine 2000;25(6):434-9.
2000: Nakopoulou L; Lazaris A C; Kavantzas N; Alexandrou P; Athanassiadou P; Keramopoulos A; Davaris P
DNA topoisomerase II-alpha immunoreactivity as a marker of tumor aggressiveness in invasive breast cancer.
Pathobiology : journal of immunopathology, molecular and cellular biology 2000;68(3):137-43.
2000: Nakopoulou L; Gakiopoulou H; Keramopoulos A; Giannopoulou I; Athanassiadou P; Mavrommatis J; Davaris P S
c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma.
Histopathology 2000;36(4):313-25.
2000: Yannakoulia M; Keramopoulos A; Tsakalakos N; Matalas A L
Body composition in dancers: the bioelectrical impedance method.
Medicine and science in sports and exercise 2000;32(1):228-34.
2000: Elsheikh A; Keramopoulos A; Lazaris D; Ambela C; Louvrou N; Michalas S
Breast tumors during adolescence.
European journal of gynaecological oncology 2000;21(4):408-10.
1999: Nakopoulou L; Michalopoulou A; Giannopoulou I; Tzonou A; Keramopoulos A; Lazaris A C; Davaris P S
bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.
Histopathology 1999;34(4):310-9.
1998: Papadimitriou C A; Dimopoulos M A; Ampela C; Louvrou-Fertaki A; Anagnostopoulos A; Athanassiades P; Stamatelopoulos S; Keramopoulos A
Sequential administration of doxorubicin and paclitaxel followed by cyclophosphamide, methotrexate and 5-fluorouracil combination (CMF) in women with metastatic breast cancer.
Oncology 1998;55(6):533-7.
1996: Nakopoulou L L; Alexiadou A; Theodoropoulos G E; Lazaris A C; Tzonou A; Keramopoulos A
Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer.
The Journal of pathology 1996;179(1):31-8.
1993: Keramopoulos A; Tsionou C; Minaretzis D; Michalas S; Aravantinos D
Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach.
Oncology 1993;50(6):445-9.
1991: Keramopoulos A; Tsionou C; Minaretzis D; Aravantinos D
Breast disease management in an obstetrics and gynecology department.
American journal of obstetrics and gynecology 1991;165(2):484-5.
1983: Karapas N; Gerali S; Keramopoulos A; Aravantinos D
[Internal breast scintigraphy using rhenium 99mTc. Contribution to delimiting the area of radiotherapy of cancer]
Journal de gynécologie, obstétrique et biologie de la reproduction 1983;12(3):259-62.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Antonios Keramopoulos

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Anatomy

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Antonios Keramopoulos (preview)

All Publications